BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3093446)

  • 1. Beta-lactam antibiotics and mycobacteria.
    Finch R
    J Antimicrob Chemother; 1986 Jul; 18(1):6-8. PubMed ID: 3093446
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative in vitro activity of the new macrolide A-56268 against mycobacteria.
    Berlin OG; Young LS; Floyd-Reising SA; Bruckner DA
    Eur J Clin Microbiol; 1987 Aug; 6(4):486-7. PubMed ID: 2959472
    [No Abstract]   [Full Text] [Related]  

  • 3. Contribution of beta-lactamase production to the resistance of mycobacteria to beta-lactam antibiotics.
    Quinting B; Reyrat JM; Monnaie D; Amicosante G; Pelicic V; Gicquel B; Frère JM; Galleni M
    FEBS Lett; 1997 Apr; 406(3):275-8. PubMed ID: 9136901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-lactam inhibitors of beta-lactamases in Mycobacterium].
    Galán JC
    Rev Esp Quimioter; 1998 Dec; 11(4):386-8. PubMed ID: 10336326
    [No Abstract]   [Full Text] [Related]  

  • 5. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
    Thomas L; Naumann P; Crea A
    Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifurtimox Is Ineffective against Drug-Resistant Mycobacteria.
    Ruth MM; Sangen JJN; Wertheim HFL; van Ingen J
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652235
    [No Abstract]   [Full Text] [Related]  

  • 7. Distribution and characterization of beta-lactamases of mycobacteria and related organisms.
    Kwon HH; Tomioka H; Saito H
    Tuber Lung Dis; 1995 Apr; 76(2):141-8. PubMed ID: 7780097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New active drugs against the tuberculosis bacillus and other mycobacteria].
    de Kantor IN
    Medicina (B Aires); 1986; 46(1):107-12. PubMed ID: 3100907
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppression of the growth of six potentially-pathogenic mycobacteria by beta-lactam/beta-lactamase-inhibitors.
    Prabhakaran K; Harris EB; Randhawa B
    Microbios; 1997; 91(366):7-14. PubMed ID: 9467917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
    Davies S; Sparham PD; Spencer RC
    J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising new drugs in the treatment of tuberculosis and mycobacteriosis.
    Casal M; Rodríguez F; Gutierrez J; Ruiz P; Benavente MC; Villalba R; Moreno G
    J Chemother; 1989 Feb; 1(1):39-45. PubMed ID: 2498468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.
    Rastogi N; Goh KS; David HL
    Ann Inst Pasteur Microbiol; 1988; 139(2):233-7. PubMed ID: 3165641
    [No Abstract]   [Full Text] [Related]  

  • 13. beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic.
    Prabhakaran K; Harris EB; Randhawa B; Hastings RC
    Microbios; 1995; 81(328):177-85. PubMed ID: 7752957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics.
    Flores AR; Parsons LM; Pavelka MS
    Microbiology (Reading); 2005 Feb; 151(Pt 2):521-532. PubMed ID: 15699201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex.
    Steadham JE; Stall SK; Simmank JL
    Diagn Microbiol Infect Dis; 1985 Jan; 3(1):33-40. PubMed ID: 3917885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterial plasmids: screening and possible relationship to antibiotic resistance in Mycobacterium avium/Mycobacterium intracellulare.
    Franzblau SG; Takeda T; Nakamura M
    Microbiol Immunol; 1986; 30(9):903-7. PubMed ID: 3540539
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary study of the in vitro activity of irloxacin against mycobacteria.
    Casal M; Gutierrez J; Ruiz P; Moreno G
    Chemotherapy; 1995; 41(3):204-7. PubMed ID: 7656667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sch 29482: comparative activity against Enterobacteriaceae multiply-resistant to beta-lactam antibiotics and mycobacteria.
    Sanders CC; Sanders WE
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():59-69. PubMed ID: 6977534
    [No Abstract]   [Full Text] [Related]  

  • 19. New antimycobacterial S-alkylisothiosemicarbazones.
    Waisser K; Heinisch L; Slosárek M; Janota J
    Folia Microbiol (Praha); 2005; 50(6):479-81. PubMed ID: 16681143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two groups of Mycobacterium avium complex strains determined according to the susceptibility to rifampicin and ansamycin.
    Tsukamura M
    Microbiol Immunol; 1987; 31(7):615-23. PubMed ID: 3125413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.